Inositol Treatment in Different Type of PCOS Phenotype

The Effect of Inositol Treatment in Women With PCOS of Different Phenotype

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05678114

Enrollment

120

Registered

2023-01-10

Start date

2022-12-21

Completion date

2023-05-12

Last updated

2023-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome

Brief summary

Evaluation of the efficacy of inositol treatment in women with PCOS in relation to the phenotype (according to the Rotterdam Criteria)

Interventions

DIETARY_SUPPLEMENTMyo-inositol

Myo-inositol (4g/die)

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

* women with PCOS of any phenotype

Exclusion criteria

* hormonal treatment (such as contraceptive pill) * use of supplements containing myo-inositol * severe co-morbidities

Design outcomes

Primary

Measure	Time frame	Description
Regularization of the menstrual cycle	Change from baseline number of women with irregular menstrual cycle at 4 months	Number of women with regular/altered menstrual cycle

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026